ENTRY       D00530                      Drug
NAME        Zaleplon (JAN/USP/INN);
            Sonata (TN)
PRODUCT
  GENERIC   ZALEPLON (Aurobindo Pharma Limited)
            ZALEPLON (Bryant Ranch Prepack)
            ZALEPLON (Bryant Ranch Prepack)
            ZALEPLON (Bryant Ranch Prepack)
            ZALEPLON (Bryant Ranch Prepack)
            ZALEPLON (Bryant Ranch Prepack)
            ZALEPLON (PD-Rx Pharmaceuticals)
            ZALEPLON (PD-Rx Pharmaceuticals)
            ZALEPLON (PD-Rx Pharmaceuticals)
            ZALEPLON (Preferred Pharmaceuticals)
            ZALEPLON (Rising Health)
            ZALEPLON (Unichem Pharmaceuticals (USA))
            ZALEPLON (West-Ward Pharmaceuticals Corp.)
            ZALEPLON (medsource pharmaceuticals)
FORMULA     C17H15N5O
EXACT_MASS  305.1277
MOL_WEIGHT  305.3339
CLASS       Neuropsychiatric agent
             DG01836  Non-benzodiazepine sedative-hypnotics
             DG03202  Hypnotic
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02953  AOX1 substrate
REMARK      Same as: C07484
            ATC code: N05CF03
            Product: D00530<US>
EFFICACY    Sedative-hypnotic
  DISEASE   Insomnia [DS:H01609]
COMMENT     Non-benzodiazepines
TARGET      GABRA1 [HSA:2554] [KO:K05175]
  PATHWAY   hsa04080(2554)  Neuroactive ligand-receptor interaction
            hsa04727(2554)  GABAergic synapse
METABOLISM  Enzyme: AOX1 [HSA:316], CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07032  Hypnotics
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05C HYPNOTICS AND SEDATIVES
                N05CF Benzodiazepine related drugs
                 N05CF03 Zaleplon
                  D00530  Zaleplon (JAN/USP/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Sleep Disorder Agents
              Sleep Promoting Agents
               Zaleplon
                D00530  Zaleplon (JAN/USP/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01836  Non-benzodiazepine sedative-hypnotics
               D00530  Zaleplon
              DG03202  Hypnotic
               D00530  Zaleplon
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D00530  Zaleplon
              DG02953  AOX1 substrate
               D00530  Zaleplon
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG03202  Hypnotic
               D00530  Zaleplon
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Ligand-gated ion channels
               GABA (ionotropic)
                GABRA1
                 D00530  Zaleplon (JAN/USP/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D00530
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D00530
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00530
DBLINKS     CAS: 151319-34-5
            PubChem: 7847596
            ChEBI: 10102
            LigandBox: D00530
            NIKKAJI: J575.185C
ATOM        23
            1   N4y N    21.5593  -17.9656
            2   C8y C    20.3721  -17.2521
            3   C8y C    21.5593  -19.3283
            4   N5x N    22.8927  -17.5036
            5   C8y C    20.3721  -15.8719
            6   C8x C    19.1615  -17.9656
            7   C8y C    22.8927  -19.7726
            8   N5x N    20.3721  -20.0476
            9   C8x C    23.6998  -18.6499
            10  C8x C    21.5593  -15.1643
            11  C8x C    19.1615  -15.1643
            12  C8x C    19.1615  -19.3283
            13  C3b C    23.3721  -21.1002
            14  C8y C    21.5593  -13.7314
            15  C8x C    19.1322  -13.7899
            16  N1c N    22.7816  -13.0238
            17  C8x C    20.3721  -13.0764
            18  C5a C    22.7465  -11.6554
            19  C1b C    23.9863  -13.6905
            20  C1a C    23.9337  -10.9302
            21  O5a O    21.5183  -10.9829
            22  C1a C    25.1734  -12.9653
            23  N3a N    23.8700  -22.4000
BOND        25
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 2
            6     3   7 2
            7     3   8 1
            8     4   9 2
            9     5  10 1
            10    5  11 2
            11    6  12 1
            12    7  13 1
            13   10  14 2
            14   11  15 1
            15   14  16 1
            16   14  17 1
            17   16  18 1
            18   16  19 1
            19   18  20 1
            20   18  21 2
            21   19  22 1
            22    7   9 1
            23    8  12 2
            24   15  17 2
            25   13  23 3
///
